SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5tu0'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FE2_A_LAXA700_1
(PROSTAGLANDIN
ENDOPEROXIDE H
SYNTHASE-1)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
5 / 10 VAL A 113
VAL A  52
VAL A  42
ASN A 329
LEU A 321
None
1.16A 1fe2A-5tu0A:
undetectable
1fe2A-5tu0A:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XLS_A_9CRA801_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
6 / 12 ILE A 265
ALA A 262
ALA A 263
LEU A 167
PHE A 185
LEU A 186
None
1.50A 1xlsA-5tu0A:
undetectable
1xlsA-5tu0A:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XLS_B_9CRB802_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
6 / 12 ILE A 265
ALA A 262
ALA A 263
LEU A 167
PHE A 185
LEU A 186
None
1.49A 1xlsB-5tu0A:
undetectable
1xlsB-5tu0A:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XLS_C_9CRC803_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
6 / 12 ILE A 265
ALA A 262
ALA A 263
LEU A 167
PHE A 185
LEU A 186
None
1.49A 1xlsC-5tu0A:
undetectable
1xlsC-5tu0A:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XLS_D_9CRD804_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
6 / 12 ILE A 265
ALA A 262
ALA A 263
LEU A 167
PHE A 185
LEU A 186
None
1.50A 1xlsD-5tu0A:
undetectable
1xlsD-5tu0A:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA6_A_SCKA902_1
(ACETYLCHOLINESTERASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
5 / 10 GLU A 165
ASN A 182
LEU A 198
LEU A 290
TYR A 202
PGE  A 503 (-3.8A)
None
None
None
None
1.48A 2ha6A-5tu0A:
undetectable
2ha6A-5tu0A:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HA6_B_SCKB952_1
(ACETYLCHOLINESTERASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
5 / 10 GLU A 165
ASN A 182
LEU A 198
LEU A 290
TYR A 202
PGE  A 503 (-3.8A)
None
None
None
None
1.47A 2ha6B-5tu0A:
undetectable
2ha6B-5tu0A:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y05_A_RALA801_1
(PROSTAGLANDIN
REDUCTASE 1)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 8 VAL A 206
SER A 103
VAL A 413
TYR A 417
None
1.26A 2y05A-5tu0A:
undetectable
2y05B-5tu0A:
undetectable
2y05A-5tu0A:
25.44
2y05B-5tu0A:
25.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YVL_B_SAMB602_1
(HYPOTHETICAL PROTEIN)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
3 / 3 GLU A 410
ASP A 216
TYR A 205
None
0.78A 2yvlB-5tu0A:
undetectable
2yvlB-5tu0A:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ADS_B_IMNB3_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
5 / 12 ILE A 374
GLY A 211
ALA A 200
LEU A 219
VAL A 380
None
1.38A 3adsB-5tu0A:
undetectable
3adsB-5tu0A:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BRF_A_SORA2_0
(LIN-12 AND GLP-1
PHENOTYPE PROTEIN 1,
ISOFORM A)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
3 / 3 LYS A  56
LYS A  49
VAL A  52
None
1.05A 3brfA-5tu0A:
undetectable
3brfA-5tu0A:
23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BXO_A_SAMA238_1
(N,N-DIMETHYLTRANSFER
ASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
3 / 3 TYR A 148
GLU A 143
ASP A  99
None
MAL  A 501 ( 4.2A)
MAL  A 501 (-3.8A)
0.86A 3bxoA-5tu0A:
undetectable
3bxoA-5tu0A:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BXO_B_SAMB238_1
(N,N-DIMETHYLTRANSFER
ASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
3 / 3 TYR A 148
GLU A 143
ASP A  99
None
MAL  A 501 ( 4.2A)
MAL  A 501 (-3.8A)
0.89A 3bxoB-5tu0A:
undetectable
3bxoB-5tu0A:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TOP_A_ACRA1_2
(MALTASE-GLUCOAMYLASE
, INTESTINAL)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 5 ILE A 253
TRP A 239
TRP A 234
THR A 289
None
None
PGE  A 503 (-3.8A)
None
1.38A 3topA-5tu0A:
undetectable
3topA-5tu0A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TOP_B_ACRB1_2
(MALTASE-GLUCOAMYLASE
, INTESTINAL)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 5 PRO A 288
ILE A 253
TRP A 239
TRP A 234
None
None
None
PGE  A 503 (-3.8A)
1.35A 3topB-5tu0A:
undetectable
3topB-5tu0A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VYW_C_SAMC401_0
(MNMC2)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
5 / 12 GLY A 197
GLY A 204
TYR A 205
PHE A 299
LEU A 145
None
1.12A 3vywC-5tu0A:
undetectable
3vywC-5tu0A:
20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_C_STRC601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 5 ILE A 141
ASP A 335
GLU A 339
VAL A 361
None
1.21A 4nkxC-5tu0A:
undetectable
4nkxC-5tu0A:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_D_STRD601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 5 ILE A 141
ASP A 335
GLU A 339
VAL A 361
None
1.20A 4nkxD-5tu0A:
undetectable
4nkxD-5tu0A:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RP8_C_ASCC501_1
(ASCORBATE-SPECIFIC
PERMEASE IIC
COMPONENT ULAA)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
3 / 3 SER A 271
TYR A 275
ASP A 250
None
0.83A 4rp8C-5tu0A:
1.2
4rp8C-5tu0A:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZO1_X_T3X500_1
(THYROID HORMONE
RECEPTOR BETA)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
5 / 12 ILE A 141
ALA A 342
ARG A 347
ALA A 300
MET A  74
None
1.49A 4zo1X-5tu0A:
undetectable
4zo1X-5tu0A:
21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IWU_A_ERYA404_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E II)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 6 GLY A 304
ILE A 362
ARG A 347
TYR A 365
None
1.10A 5iwuA-5tu0A:
undetectable
5iwuA-5tu0A:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N0O_A_SAMA501_1
(PEPTIDE
N-METHYLTRANSFERASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
3 / 3 ALA A 249
GLN A 244
THR A 190
None
0.70A 5n0oA-5tu0A:
undetectable
5n0oA-5tu0A:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N0R_A_SAMA501_1
(PEPTIDE
N-METHYLTRANSFERASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 4 SER A 248
ALA A 249
GLN A 244
THR A 190
None
1.21A 5n0rA-5tu0A:
1.2
5n0rA-5tu0A:
20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N0S_A_SAMA501_1
(PEPTIDE
N-METHYLTRANSFERASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 4 SER A 248
ALA A 249
GLN A 244
THR A 190
None
1.18A 5n0sA-5tu0A:
undetectable
5n0sA-5tu0A:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N0W_A_SAMA501_1
(PEPTIDE
N-METHYLTRANSFERASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 4 SER A 248
ALA A 249
GLN A 244
THR A 190
None
1.18A 5n0wA-5tu0A:
undetectable
5n0wA-5tu0A:
20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N0W_B_SAMB501_1
(PEPTIDE
N-METHYLTRANSFERASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 5 SER A 248
ALA A 249
GLN A 244
THR A 190
None
1.16A 5n0wB-5tu0A:
undetectable
5n0wB-5tu0A:
20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N0X_A_SAMA501_1
(PEPTIDE
N-METHYLTRANSFERASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 4 SER A 248
ALA A 249
GLN A 244
THR A 190
None
1.17A 5n0xA-5tu0A:
1.3
5n0xA-5tu0A:
20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N4I_A_SAMA501_1
(PEPTIDE
N-METHYLTRANSFERASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
4 / 5 SER A 248
ALA A 249
GLN A 244
THR A 190
None
1.16A 5n4iA-5tu0A:
undetectable
5n4iA-5tu0A:
21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TQR_B_SAMB8009_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2, POLYCOMB
PROTEIN SUZ12)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
5 / 10 LEU A 154
GLY A 283
TYR A 282
VAL A 146
TYR A 275
None
1.32A 5tqrB-5tu0A:
undetectable
5tqrB-5tu0A:
16.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W4Z_A_RBFA502_1
(RIBOFLAVIN LYASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
5 / 12 GLY A 137
ALA A 138
SER A 311
VAL A  93
THR A 325
None
0.95A 5w4zA-5tu0A:
undetectable
5w4zA-5tu0A:
10.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W4Z_B_RBFB502_1
(RIBOFLAVIN LYASE)
5tu0 LMO2125 PROTEIN
(Listeria
monocytogenes)
5 / 12 GLY A 137
ALA A 138
SER A 311
VAL A  93
THR A 325
None
0.96A 5w4zB-5tu0A:
undetectable
5w4zB-5tu0A:
10.62